Sun Pharma pulls 1 million boxes of generic Claritin in further Ranbaxy cleanup

Sun Pharmaceutical isn't just cleaning up in India after recently buying Ranbaxy Laboratories. It's also tasked with resolving issues at Ranbaxy's U.S. manufacturing operation, Ohm Laboratories, which is recalling more than 1 million boxes of loratadine, its generic version of Bayer's allergy med Claritin. More from FiercePharmaManufacturing

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.